Cell Signaling Technology

Product Pathways - MAPK Signaling

Phospho-MAPK Family Rabbit mAb Sampler Kit #9938

Kit Includes Quantity Applications Reactivity MW (kDa) Source
Phospho-p44/42 MAPK (Thr202/Tyr204) (D13.14.4E) Rabbit mAb # 4370 40 microliters W IP IHC-P IF-IC F H M R Mk Mi Hm B Dr Z 44, 42 kDa Rabbit
Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit mAb # 4668 40 microliters W IP IHC-P H M R Dr 46, 54 Rabbit
Phospho-p38 MAPK (Thr180/Tyr182)(12F8) Rabbit mAb (IHC Preferred) # 4631 40 microliters W IHC-P IF-IC H M R Mk Mi Dr 43 Rabbit
Anti-rabbit IgG, HRP-linked Antibody # 7074 50 microliters Goat
U0126 (MEK1/2 Inhibitor) # 9903 0.3 milligrams

Applications Key:  W=Western Blotting  IP=Immunoprecipitation  IHC-P=Immunohistochemistry (Paraffin)  IF-IC=Immunofluorescence (Immunocytochemistry)  F=Flow Cytometry
Reactivity Key:  H=Human  M=Mouse  R=Rat  Mk=Monkey  Mi=Mink  Hm=Hamster  B=Bovine  Dr=Drosophila  Z=Zebra Fish

Specificity / Sensitivity

Phospho-p44/42 MAPK, Phospho-SAPK/ JNK and Phospho-p38 MAPK Rabbit mAbs recognize only the phosphorylated form of p44/42 MAPK, SAPK/JNK and p38 MAPK, respectively. They do not cross-react with other MAPK family members.

Western Blotting

Western Blotting

Western blot analysis of extracts from 293, NIH/3T3 and C6 cells, treated with λ phosphatase or TPA as indicated, using Phospho-p44/42 MAPK (Thr202/Tyr204) (D13.14.4E) Rabbit mAb #4370 (upper), or p44/42 MAP Kinase (137F5) Rabbit mAb #4695 (lower).

Western Blotting

Western Blotting

Western blot analysis of extracts from Jurkat, NIH/3T3, and PC12 cells, untreated or treated as indicated, using Phospho-p38 MAP Kinase (Thr180/Tyr182) (12F8) Rabbit mAb (IHC Preferred) #4631.

Western Blotting

Western Blotting

Western blot analysis of extracts from 293 cells, untreated or UV-treated, NIH/3T3 cells, untreated or UV-treated and C6 cells, untreated or anisomycin-treated, using Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit mAb #4668.


IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded NIH/3T3 cells, untreated (left) or PMA-treated (right), using Phospho-p44/42 MAPK (Thr202/Tyr204) (D13.14.4E) Rabbit mAb #4370.

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma using Phospho-p44/42 MAPK (Thr202/Tyr204) (D13.14.4E) Rabbit mAb #4370.

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human lung carcinoma, untreated (left) or λ phosphatase-treated (right), using Phospho-p44/42 MAPK (Thr202/Tyr204) (D13.14.4E) Rabbit mAb #4370.


IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemistry of paraffin-embedded lung carcinoma, showing nuclear localization, using Phospho-p38 MAP Kinase (Thr180/Tyr182) (12F8) Rabbit Monoclonal Antibody (IHC Preferred) #4631.

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemistry of paraffin-embedded human glioblastoma, untreated (left) or CIP phosphatase-treated (right), using Phospho-p38 MAP Kinase (Thr180/Tyr182) (12F8) Rabbit Monoclonal Antibody (IHC Preferred) #4631.

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemistry of paraffin-embedded breast carcinoma, using Phospho-p38 MAP Kinase (Thr180/Tyr182) (12F8) Rabbit Monoclonal Antibody (IHC Preferred) #4631 (left) or the same antibody pre-incubated with antigen phospho-peptide (right).


IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded 293T cells untreated (left) or UV-treated (right) using Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit mAb #4668.

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human lung carcinoma using Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit mAb in the presence of control peptide (left) or Phospho-SAPK/JNK (Thr183/Tyr185) Blocking Peptide #1215 (right).

Flow Cytometry

Flow Cytometry

Flow cytometric analysis of Jurkat cells, U0126-treated (blue) or PMA-treated (green), using Phospho-p44/42 MAPK (Thr202/Tyr204) (D13.14.4E) Rabbit mAb #4370.


Flow Cytometry

Flow Cytometry

Flow cytometric analysis of HeLa cells, untreated (blue) or UV-treated (green), using Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit mAb #4668 compared to a nonspecific negative control antibody (red).

IF-IC

IF-IC

Confocal immunofluorescent analysis of C2C12 cells, U0126-treated (left, #9903 10 μM for 1 h) or TPA-treated (right, #9905 200 nM for 15 min), using Phospho-p44/42 MAPK (Thr202/Tyr204) (D13.14.4E) Rabbit mAb #4370 (green). Actin filaments have been labeled with Alexa Fluor® 555 phalloidin (red). Blue pseudocolor = DRAQ5™ (fluorescent DNA dye).

IF-IC

IF-IC

Confocal immunofluorescent analysis of HeLa cells, untreated (left) or anisomycin-treated (right), using Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit mAb #4668 (green). Actin filaments have been labeled with Alexa Fluor® 555 phalloidin (red).


Source / Purification

Monoclonal antibodies are produced by immunizing rabbits with synthetic phosphorylated peptides corresponding to residues surrounding Thr202/Tyr204 of human p44 MAPK (Erk1), Thr183/Tyr185 of human SAPK or Thr180/Tyr182 of human p38. For MEK1/2 Inhibitor (U0126) #9903 information, see page 3.

Background

p44/42 MAPK (Erk1 and Erk2), SAPK/JNK and p38 MAPK function in protein kinase cascades that play a critical role in the regulation of cell growth, differentiation and control of cellular responses to cytokines and stress.p44/42 MAPK (Erk1 and Erk2) is activated by growth and neurotrophic factors. Activation occurs through phosphorylation of threonine and tyrosine residues (Thr202 and Tyr204 in human Erk1) at the sequence T*EY* by a single upstream MAP kinase kinase (MEK).SAPK/JNK and p38 MAPK are activated by inflammatory cytokines and by a wide variety of cellular stresses. Activation of SAPK/JNK occurs via phosphorylation at Thr183 and Tyr185 by the dual specificity enzyme SEK/MKK4. Both MKK3 and SEK phosphorylate p38 MAPK on tyrosine and threonine at the sequence T*GY* to activate p38 MAP kinase.

  1. Lewis, T. S. et al. (1998) Adv. Cancer Res. 74, 49-139.
  2. Garrington, T.P. and Johnson, G.L. (1999) Curr. Opin. Cell. Biol. 11, 211-218.
  3. Schaeffer, H.J. and Weber, M.J. (1999) Mol. Cell. Biol. 19, 2435-2444.
  4. Whitmarsh, A.J. and Davis, R.J. (1998) Trends Biochem. Sci. 23, 481-485.
  5. Cobb, M.H. (1999) Prog. Biophys. Mol. Biol. 71, 479-500.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

Rabbit Monoclonals Produced Using Epitomics® Technology, U.S. Patent No. 5,675,063.

Product Pathways

Drug Discovery Tools

Featured Technologies

Protein Classes